5.87% -5.91

Dopo l'orario di chiusura: 94.84

Revvity Inc (RVTY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RVTY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Revvity Inc (RVTY)

Revvity Inc Borsa (RVTY) Ultime notizie

Revvity Q1 2025 Earnings Preview: CEO and CFO to Detail Financial Performance - Stock Titan

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo - Yahoo

FDA greenlights Revvity’s TB diagnostic platform By Investing.com - Investing.com South Africa

Revvity (RVTY) Gains FDA Approval for Automated TB Test - GuruFocus

What's Going On With Revvity Stock Today? - Benzinga

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test - 01net

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating - MarketScreener

FDA Approves Revvity’s Improved Automated Latent Tuberculosis Test - Medical Product Outsourcing

Revvity gets FDA nod for its automated tuberculosis test (RVTY:NYSE) - Seeking Alpha

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test - MarketScreener

FDA greenlights Revvity’s TB diagnostic platform - Investing.com India

Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis Test - MarketScreener

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research

Game-Changing TB Test: Revvity's New FDA-Approved System Cuts Testing Time by 70% - Stock Titan

Pictet Asset Management Holding SA Has $125.17 Million Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Is Revvity Stock Underperforming the Nasdaq? - MSN

High Content Screening/Imaging Technology Analysis and Global Market Forecasts 2025-2029 with Danaher, Revvity, Thermo Fischer Scientific, Agilent Technologies and Yokogawa LeadingResearchAndMarkets.com - Bluefield Daily Telegraph

Is Revvity Stock Underperforming The Nasdaq? - Barchart

Is Revvity Gaining or Losing Market Support? - Benzinga

Revvity Expands Alliance With Genomics England To Drive Research Into Newborn Genomic Sequencing in England - Technology Networks

Revvity Stock Tumbles Despite Expanding Genomics England Alliance - MSN

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years - Yahoo Finance

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England - BioSpace

Revvity Expands Alliance with Genomics England -March 20, 2025 at 02:10 pm EDT - MarketScreener

Massive Breakthrough: Revvity's 100K Newborn Genetic Screening Program Targets 200 Rare Diseases - StockTitan

May 16th Options Now Available For Revvity (RVTY) - Nasdaq

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now? - Simply Wall St

Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Revvity's AI-Powered Cellular Imaging & Research Antibodies - openPR

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating - MarketScreener

Learn to Evaluate (RVTY) using the Charts - Stock Traders Daily

Revvity at Leerink Global Healthcare Conference: Strategic Resilience Amid Challenges - Investing.com

Jones Financial Companies Lllp Acquires 1,228 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World

Mutual of America Capital Management LLC Cuts Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World

PerkinElmer Stock Price | RVTY Stock Quote, News, and History - Markets Insider

Sanctuary Advisors LLC Purchases Shares of 1,872 Revvity, Inc. (NYSE:RVTY) - Defense World

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay - Technology Networks

Revvity, Inc. (NYSE:RVTY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Revvity Expands Measles Testing Accessibility with EUROIMMUN Anti-Measles Virus ELISA 2.0 - Lab Manager Magazine

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance

What Does the Market Think About Revvity? - Benzinga

Private Advisor Group LLC Grows Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection -March 03, 2025 at 10:28 am EST - Marketscreener.com

High-Throughput Screening Technology Analysis and Global - GlobeNewswire

High-Throughput Screening Technology Analysis and Global Markets 2021-2024 & 2025-2029 with Danaher, Thermo Fisher Scientific., Charles River Laboratories, Revvity and Bio-Rad Laboratories Leading - Yahoo Finance

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Jefferies raises Revvity stock price target to $130, maintains Hold - MSN

Is Revvity, Inc.'s (NYSE:RVTY) Stock Price Struggling As A Result Of Its Mixed Financials? - Simply Wall St

3 Reasons to Sell RVTY and 1 Stock to Buy Instead - Yahoo Finance

Principal Financial Group Inc. Sells 4,253 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World

New York State Common Retirement Fund Reduces Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? - MSN

Simile a RVTY